Determinants of long term survival after surgery for cancer of the lung: A population-based study

Cancer

Volumn 86, Issue 11, 1999, Pages 2229-2237

  Bouchardy, Christine ^a   Fioretta, Gérald ^a   De Perrot, Marc ^b   Obradovic, Mirjana ^a   Spiliopoulos, Anastase ^b  

^a GENEVA CANCER REGISTRY   (Switzerland)

^b UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cancer registry; Gender; Long term survival; Lung carcinoma; Prognostic factors

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; SEX DIFFERENCE; SOCIAL STATUS; TUMOR DIFFERENTIATION;

ADULT; AGED; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; REGISTRIES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 0033429046     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991201)86:11<2229::AID-CNCR9>3.0.CO;2-K     Document Type: Article

References (29)

1. Levi F, Raymond L, Schüler G, Fisch T, Bouchardy C, Alleman I, et al. Cancer en Suisse. Faits et commentaires. Berne: Ligue Suisse contre le Cancer, 1998.
2. La Vecchia C, Lucchini F, Negri E, Boyle P, Maisonneuve P, Levi F. Trends in cancer mortality in Europe, 1955-1989:II. Respiratory tract, bone, connective and soft tissue sarcomas, and skin. Eur J Cancer 1992;28:514-99.
3. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J, editors. Results. Lung. In: Survival of cancer patients in Europe. The Eurocare Study. IARC Scientific Pub No. 132. Chapter 17. Lyon: International Agency for Research on Cancer, 1995:232-44.
4. Obradovic M, Fioretta G, Droin N, Raymond L, Bouchardy C. Le cancer à Genève. Incidence, mortalité, survie 1970-1994. Geneva: Département de l'action sociale et de la santé, Registre Genevois des Tumeurs, 1997.
5. Ferguson MK, Skosey C, Hoffman PC, Golomb HM. Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol 1990;8:1402-7.
6. Paesmans M, Sculier JP, Libert P, Bureau G, Dabouis J, Thiriaux J, et al. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multi-variate analyses including recursive partioning and amalgamation algorithms in 1,052 patients. J Clin Oncol 1995;13:1221-30.
7. Palomares MR, Sayre JW, Shekar KC, Lillington LM, Chlebowski RT. Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients. Cancer 1996;78:2119-26.
8. Bouchardy C. Switzerland, Geneva. In: Parkin DM, Whelan SL, Ferlay I, Raymond L, Young J, editors. Cancer incidence in five continents. Volume 7. IARC Scientific Pub No. 143. Lyon: International Agency for Research on Cancer, 1997: 666-9.
9. World Health Organization. International classification of diseases for oncology, ICD-O. 1st edition. Geneva: World Health Organization, 1976.
10. Raymond L, Fischer B, Fioretta G, Bouchardy C. Migration bias in cancer survival rates. J Epidemiol Biostat 1996;1:167-73.
11. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Volume 1. Geneva: World Health Organization, 1967.
12. Summary Staging Guide for Cancer Surveillance, Epidemiology and End Results Reporting Program, April 1977. NIH Pub. No. 82-2313. In: Shambaugh EM, Weiss MA, Axtell LM, editors. Bethesda: U.S. Department of Health and Human Services, National Institutes of Health, 1982.
13. TNM Classification of Malignant Tumours. 2nd edition. Geneva: International Union Against Cancer, 1975.
14. TNM Classification of Malignant Tumours. 3rd edition. Geneva: International Union Against Cancer, 1978.
15. World Health Organization. Histologie typing of lung tumours. 2nd edition. Geneva: International Union Against Cancer, 1981.
16. Bureau fédéral de statistique. Classifications des professions, des situations dans la profession, des classes économiques. Mouvement de la population. Berne: Bureau fédéral de statistique, 1979.
17. Breslow NE, Day NE. The analysis of case-control studies. In: Statistical methods in cancer research. Volume 1. IARC Scientific Pub No. 32. Lyon: International Agency for Research on Cancer, 1980:192-242.
18. Francis B, Green M, Payne C, Swant T, Gilchrist R, Bradley M, et al., editors. The Statistical System for Generalized Linear Interactive Modelling, GLIM. Release 4 manual. Oxford: Royal Statistical Society, 1993.
19. Kealey KA, Hutchinson F, editors. Centralized Cancer Patient Data System. Survival rates for U.S. comprehensive cancer center patients, admissions 1877-1982. Seattle: Cancer Research Center, 1985.
20. Johnson BE, Steinberg SM, Phelps R, Edison M, Veach SR, Ihde DC. Female patients with small cell lung cancer live longer than males patients. Am J Med 1988;85:194-6.
21. Noronha RFX, Goodall CM. Enhancement of hepatic and renal tumorigenesis in thyroidectomized NZR/Gd rats treated with dimethylnitrosamine. J Surg Oncol 1976;8:539-50.
22. Lee YT. Better prognosis of many cancers in female: a phenomenon not explained by study of steroid receptors. J Surg Oncol 1984;25:255-62.
23. Beattie CW, Hansen NW, Thomas PA. Steroid receptors in human lung cancer. Cancer Res 1985;45:4206-14.
24. Cagle PT, Mody DR, Schwartz MR. Estrogen and progesterone receptors in bronchogenic carcinoma. Cancer Res 1990; 50:6632-5.
25. Mukhopadhyay T, Roth JA. Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol. Oncogene 1997;14:379-84.
26. Vargas SO, Leslie KO, Vacek PM, Socinski MA, Weaver DL. Estrogen-receptor-related protein p29 in primary nonsmall cell lung carcinoma. Cancer 1998;82:1495-500.
27. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, et al. The endogenous oestronge mestabolite 2-methoxyostradiol inhibits angiogenesis and suppresses tumour growth. Nature 1994;368:237-9.
28. Kubik A, Parkin DM, Khlat M, Erban J, Polak J, Adamec M. Lack of benefit from semi-annual screening for cancer of the lung: follow-up of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer 1990;45:26-33.
29. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR. Lung cancer screening: the Mayo program. J Occup Med 1986;28:746-50.